# Prestige Consumer Healthcare Inc.: financial statements, quarterly

PBH · NYSE · CIK 1295947 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/pbh.md) · [Financials](/companies/pbh/financials.md) · [Filings](/companies/pbh/filings.md) · [Insiders](/companies/pbh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pbh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [286](/filings/0001295947-24-000032.md) | [283](/filings/0001295947-25-000009.md) | [277 d](/filings/0001295947-26-000016.md) | [267](/filings/0001295947-25-000029.md) | [284](/filings/0001295947-25-000039.md) | [290](/filings/0001295947-26-000008.md) | [297 d](/filings/0001295947-26-000016.md) | [250](/filings/0001295947-26-000042.md) | [274](/filings/0001295947-25-000039.md) | [283](/filings/0001295947-26-000008.md) | [282 d](/filings/0001295947-26-000016.md) | [266](/filings/0001295947-26-000042.md) |
| Cost of revenue | $m | [126](/filings/0001295947-24-000032.md) | [125](/filings/0001295947-25-000009.md) | [125 d](/filings/0001295947-26-000016.md) | [121](/filings/0001295947-25-000029.md) | [126](/filings/0001295947-25-000039.md) | [129](/filings/0001295947-26-000008.md) | [127 d](/filings/0001295947-26-000016.md) | [109](/filings/0001295947-26-000042.md) | [123](/filings/0001295947-25-000039.md) | [126](/filings/0001295947-26-000008.md) | [135 d](/filings/0001295947-26-000016.md) | [130](/filings/0001295947-26-000042.md) |
| Gross profit | $m | [160](/filings/0001295947-24-000032.md) | [158](/filings/0001295947-25-000009.md) | [152 d](/filings/0001295947-26-000016.md) | [146](/filings/0001295947-25-000029.md) | [157](/filings/0001295947-25-000039.md) | [161](/filings/0001295947-26-000008.md) | [170 d](/filings/0001295947-26-000016.md) | [140](/filings/0001295947-26-000042.md) | [152](/filings/0001295947-25-000039.md) | [157](/filings/0001295947-26-000008.md) | [146 d](/filings/0001295947-26-000016.md) | [136](/filings/0001295947-26-000042.md) |
| Operating income | $m | [88.3](/filings/0001295947-24-000032.md) | [86.8](/filings/0001295947-25-000009.md) | [82.2 d](/filings/0001295947-26-000016.md) | [72.0](/filings/0001295947-25-000029.md) | [84.3](/filings/0001295947-25-000039.md) | [92.0](/filings/0001295947-26-000008.md) | [88.4 d](/filings/0001295947-26-000016.md) | [71.8](/filings/0001295947-26-000042.md) | [79.7](/filings/0001295947-25-000039.md) | [82.5](/filings/0001295947-26-000008.md) | [75.5 d](/filings/0001295947-26-000016.md) | [52.5](/filings/0001295947-26-000042.md) |
| Income tax | $m | [16.9](/filings/0001295947-24-000032.md) | [16.5](/filings/0001295947-25-000009.md) | [17.9 d](/filings/0001295947-26-000016.md) | [9.3](/filings/0001295947-25-000029.md) | [17.3](/filings/0001295947-25-000039.md) | [19.1](/filings/0001295947-26-000008.md) | [23.8 d](/filings/0001295947-26-000016.md) | [14.3](/filings/0001295947-26-000042.md) | [26.9](/filings/0001295947-25-000039.md) | [15.1](/filings/0001295947-26-000008.md) | [10.8 d](/filings/0001295947-26-000016.md) | [9.4](/filings/0001295947-26-000042.md) |
| Net income | $m | [53.6](/filings/0001295947-24-000032.md) | [53.0](/filings/0001295947-25-000009.md) | [49.5 d](/filings/0001295947-26-000016.md) | [49.1](/filings/0001295947-25-000029.md) | [54.4](/filings/0001295947-25-000039.md) | [61.0](/filings/0001295947-26-000008.md) | [50.1 d](/filings/0001295947-26-000016.md) | [47.5](/filings/0001295947-26-000042.md) | [42.2](/filings/0001295947-25-000039.md) | [46.7](/filings/0001295947-26-000008.md) | [53.9 d](/filings/0001295947-26-000016.md) | [29.2](/filings/0001295947-26-000042.md) |
| Diluted EPS | $ per share | [1.07](/filings/0001295947-24-000032.md) | [1.06](/filings/0001295947-25-000009.md) | not reported | [0.98](/filings/0001295947-25-000029.md) | [1.09](/filings/0001295947-25-000039.md) | [1.22](/filings/0001295947-26-000008.md) | not reported | [0.95](/filings/0001295947-26-000042.md) | [0.86](/filings/0001295947-25-000039.md) | [0.97](/filings/0001295947-26-000008.md) | not reported | [0.61](/filings/0001295947-26-000042.md) |
| Basic EPS | $ per share | [1.08](/filings/0001295947-24-000032.md) | [1.07](/filings/0001295947-25-000009.md) | not reported | [0.98](/filings/0001295947-25-000029.md) | [1.10](/filings/0001295947-25-000039.md) | [1.23](/filings/0001295947-26-000008.md) | not reported | [0.96](/filings/0001295947-26-000042.md) | [0.86](/filings/0001295947-25-000039.md) | [0.98](/filings/0001295947-26-000008.md) | not reported | [0.61](/filings/0001295947-26-000042.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [60.1](/filings/0001295947-23-000034.md) | [63.6](/filings/0001295947-24-000008.md) | [46.5](/filings/0001295947-25-000017.md) | [34.3](/filings/0001295947-24-000025.md) | [51.5](/filings/0001295947-24-000032.md) | [50.9](/filings/0001295947-25-000009.md) | [97.9](/filings/0001295947-26-000016.md) | [140](/filings/0001295947-25-000029.md) | [119](/filings/0001295947-25-000039.md) | [62.4](/filings/0001295947-26-000008.md) | [63.9](/filings/0001295947-26-000042.md) | [89.1](/filings/0001295947-26-000042.md) |
| Current assets | $m | [388](/filings/0001295947-23-000034.md) | [394](/filings/0001295947-24-000008.md) | [375](/filings/0001295947-25-000017.md) | [369](/filings/0001295947-24-000025.md) | [381](/filings/0001295947-24-000032.md) | [377](/filings/0001295947-25-000009.md) | [448](/filings/0001295947-26-000016.md) | [481](/filings/0001295947-25-000029.md) | [497](/filings/0001295947-25-000039.md) | [433](/filings/0001295947-26-000008.md) | [431](/filings/0001295947-26-000042.md) | [497](/filings/0001295947-26-000042.md) |
| Total assets | $m | [3,333](/filings/0001295947-23-000034.md) | [3,340](/filings/0001295947-24-000008.md) | [3,318](/filings/0001295947-25-000017.md) | [3,308](/filings/0001295947-24-000025.md) | [3,317](/filings/0001295947-24-000032.md) | [3,329](/filings/0001295947-25-000009.md) | [3,402](/filings/0001295947-26-000016.md) | [3,432](/filings/0001295947-25-000029.md) | [3,442](/filings/0001295947-25-000039.md) | [3,495](/filings/0001295947-26-000008.md) | [3,494](/filings/0001295947-26-000042.md) | [4,569](/filings/0001295947-26-000042.md) |
| Current liabilities | $m | [130](/filings/0001295947-23-000034.md) | [127](/filings/0001295947-24-000008.md) | [117](/filings/0001295947-25-000017.md) | [114](/filings/0001295947-24-000025.md) | [107](/filings/0001295947-24-000032.md) | [103](/filings/0001295947-25-000009.md) | [107](/filings/0001295947-26-000016.md) | [110](/filings/0001295947-25-000029.md) | [135](/filings/0001295947-25-000039.md) | [140](/filings/0001295947-26-000008.md) | [121](/filings/0001295947-26-000042.md) | [154](/filings/0001295947-26-000042.md) |
| Total liabilities | $m | [1,797](/filings/0001295947-23-000034.md) | [1,739](/filings/0001295947-24-000008.md) | [1,663](/filings/0001295947-25-000017.md) | [1,627](/filings/0001295947-24-000025.md) | [1,585](/filings/0001295947-24-000032.md) | [1,541](/filings/0001295947-25-000009.md) | [1,567](/filings/0001295947-26-000016.md) | [1,576](/filings/0001295947-25-000029.md) | [1,617](/filings/0001295947-25-000039.md) | [1,665](/filings/0001295947-26-000008.md) | [1,607](/filings/0001295947-26-000042.md) | [2,652](/filings/0001295947-26-000042.md) |
| Long-term debt | $m | [1,275](/filings/0001295947-23-000034.md) | [1,210](/filings/0001295947-24-000008.md) | [1,135](/filings/0001295947-25-000009.md) | [1,100](/filings/0001295947-24-000025.md) | [1,060](/filings/0001295947-24-000032.md) | [1,000](/filings/0001295947-25-000009.md) | [992](/filings/0001295947-26-000016.md) | [993](/filings/0001295947-25-000029.md) | [993](/filings/0001295947-25-000039.md) | [1,034](/filings/0001295947-26-000008.md) | [994](/filings/0001295947-26-000042.md) | [2,007](/filings/0001295947-26-000042.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001295947-26-000042.md) | [10.5](/filings/0001295947-26-000042.md) |
| Shareholders' equity | $m | [1,536](/filings/0001295947-25-000009.md) | [1,601](/filings/0001295947-25-000009.md) | [1,655](/filings/0001295947-26-000016.md) | [1,681](/filings/0001295947-25-000039.md) | [1,732](/filings/0001295947-26-000008.md) | [1,788](/filings/0001295947-26-000008.md) | [1,835](/filings/0001295947-26-000042.md) | [1,855](/filings/0001295947-26-000042.md) | [1,825](/filings/0001295947-26-000008.md) | [1,829](/filings/0001295947-26-000008.md) | [1,888](/filings/0001295947-26-000042.md) | [1,917](/filings/0001295947-26-000042.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [62.5 d](/filings/0001295947-24-000032.md) | [71.5 d](/filings/0001295947-25-000009.md) | [66.9 d](/filings/0001295947-26-000016.md) | [54.8](/filings/0001295947-25-000029.md) | [69.8 d](/filings/0001295947-25-000039.md) | [65.1 d](/filings/0001295947-26-000008.md) | [61.8 d](/filings/0001295947-26-000016.md) | [79.0](/filings/0001295947-26-000042.md) | [57.5 d](/filings/0001295947-25-000039.md) | [78.3 d](/filings/0001295947-26-000008.md) | [42.8 d](/filings/0001295947-26-000016.md) | [70.8](/filings/0001295947-26-000042.md) |
| Capital expenditure | $m | [2.9 d](/filings/0001295947-24-000032.md) | [2.0 d](/filings/0001295947-25-000009.md) | [3.1 d](/filings/0001295947-26-000016.md) | [1.2](/filings/0001295947-25-000029.md) | [2.0 d](/filings/0001295947-25-000039.md) | [1.6 d](/filings/0001295947-26-000008.md) | [3.5 d](/filings/0001295947-26-000016.md) | [0.8](/filings/0001295947-26-000042.md) | [2.1 d](/filings/0001295947-25-000039.md) | [3.0 d](/filings/0001295947-26-000008.md) | [5.2 d](/filings/0001295947-26-000016.md) | [3.7](/filings/0001295947-26-000042.md) |
| Share repurchases | $m | [0.0 d](/filings/0001295947-24-000032.md) | [0.0 d](/filings/0001295947-25-000009.md) | [0.0 d](/filings/0001295947-26-000016.md) | [26.0](/filings/0001295947-25-000029.md) | [11.8 d](/filings/0001295947-25-000039.md) | [2.4 d](/filings/0001295947-26-000008.md) | [11.3 d](/filings/0001295947-26-000016.md) | [34.8](/filings/0001295947-26-000042.md) | [75.0 d](/filings/0001295947-25-000039.md) | [45.8 d](/filings/0001295947-26-000008.md) | [0.7 d](/filings/0001295947-26-000016.md) | [0.0](/filings/0001295947-26-000042.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [50.3](/filings/0001295947-23-000034.md) | [50.2](/filings/0001295947-24-000008.md) | [50.2](/filings/0001295947-24-000025.md) | [50.1](/filings/0001295947-24-000032.md) | [50.1](/filings/0001295947-25-000009.md) | [50.3](/filings/0001295947-25-000029.md) | [50.0](/filings/0001295947-25-000039.md) | [50.0](/filings/0001295947-26-000008.md) | [49.8](/filings/0001295947-26-000042.md) | [49.3](/filings/0001295947-25-000039.md) | [48.1](/filings/0001295947-26-000008.md) | [47.6](/filings/0001295947-26-000042.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 47,374,522 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001295947-26-000042.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.